The United States represents the largest share of the Neuralgia Treatment Market, driven by the high prevalence of neuropathic pain disorders, advanced healthcare infrastructure, and strong adoption of innovative pain management therapies. Rising cases of diabetes, shingles, and age-related neurological conditions continue to increase the demand for neuralgia treatments across the country. The...